CytomX Therapeutics Inc. (CTMX)
0.81
-0.03 (-3.69%)
At close: Jan 15, 2025, 10:43 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -201.06 | -1.08 | -3.44 | -9.19 | -3.68 | -7.44 | -18.2 | -6.76 | -5.07 | -14.86 | -29.75 |
| PS Ratio | 1.13 | 1.98 | 3.99 | 3.01 | 6.55 | 10.57 | 10.95 | 26.47 | 23.26 | 88.74 | 507.35 |
| PB Ratio | -2.41 | -1.23 | 3.11 | 6.07 | 7.37 | 4.81 | 11.23 | 5.07 | 1.42 | -5.74 | -10.17 |
| P/FCF Ratio | -2.01 | -0.93 | -2.3 | 102.46 | -2.62 | -7.93 | 4.65 | -94.63 | -6.18 | 14.95 | -51.55 |
| P/OCF Ratio | -2.04 | -0.95 | -2.33 | 57.47 | -2.68 | -8.33 | 4.61 | -195.97 | -6.54 | 14.17 | -56.26 |
| OCF/S Ratio | -0.55 | -2.08 | -1.71 | 0.05 | -2.44 | -1.27 | 2.38 | -0.14 | -3.55 | 6.26 | -9.02 |
| Debt / Equity Ratio | -0.29 | -0.21 | 0.20 | 0.50 | 0.49 | n/a | n/a | n/a | n/a | -0.04 | -0.09 |
| Quick Ratio | 1.17 | 1.55 | 2.92 | 3.21 | 3.54 | 4.55 | 6.36 | 5.26 | 12.06 | 5.98 | 2.20 |
| Current Ratio | 1.17 | 1.55 | 2.92 | 3.21 | 3.54 | 4.55 | 6.36 | 5.26 | 12.06 | 5.99 | 2.22 |
| Asset Turnover | 0.50 | 0.20 | 0.20 | 0.28 | 0.17 | 0.13 | 0.18 | 0.08 | 0.04 | 0.07 | 0.06 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -35.28 | -19.17 | -61.12 | -58.88 |
| Return on Equity (ROE) | 0.01 | 1.13 | -0.9 | -0.66 | -2 | -0.65 | -0.62 | -0.75 | -0.28 | 0.39 | 0.34 |
| Return on Assets (ROA) | -0.00 | -0.37 | -0.24 | -0.09 | -0.3 | -0.19 | -0.11 | -0.3 | -0.18 | -0.41 | -1.07 |
| Return on Capital (ROIC) | -0.14 | -0.94 | -0.36 | -0.19 | -0.43 | -0.22 | -0.14 | -0.36 | -0.18 | -0.48 | -1.49 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.19 | n/a | n/a |
| Gross Profit Margin | 100.00% | 88.98% | 91.61% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | -0.56% | -183.02% | -115.92% | -32.77% | -177.84% | -142.19% | -60.17% | -391.54% | -458.69% | -597.01% | -1.71K% |
| Pretax Profit Margin | 3.28% | -186.82% | -120.17% | -46.63% | -178.58% | -118.15% | -60.89% | -391.67% | -458.56% | -596.81% | -1.70K% |
| Operating Profit Margin | -6.41% | -190.61% | -120.42% | -48.43% | -192.9% | -130.88% | -64.59% | -396.1% | -430.54% | -586.27% | -1.68K% |
| FCF Margin | -56.19% | -211.67% | -173.4% | 2.94% | -250.44% | -133.29% | 235.70% | -27.97% | -376.15% | 593.64% | -984.23% |
| EBITDA Margin | -4.26% | -186.02% | -162.9% | -77.69% | -241.57% | -127.71% | -58.59% | -384.58% | -420.46% | -571.79% | -1.60K% |